Loading...
XSTO
SDOS
Market cap7mUSD
May 23, Last price  
1.26SEK
1D
1.61%
1Q
-17.11%
Jan 2017
-73.02%
IPO
-90.77%
Name

ScandiDos AB

Chart & Performance

D1W1MN
P/E
—
P/S
1.19
EPS
—
Div Yield, %
—
Shrs. gr., 5y
9.57%
Rev. gr., 5y
4.36%
Revenues
60m
-1.82%
28,933,00035,979,00039,834,00038,699,00032,923,00033,576,00047,408,00050,570,00048,824,00057,271,00059,990,00057,684,00061,550,00060,429,000
Net income
-15m
L+60.62%
321,000227,000-2,093,000-4,200,000-14,683,000-14,242,000-13,157,000-11,565,000-17,761,000-13,134,000-1,399,000-7,338,000-9,119,000-14,647,000
CFO
1m
P
2,311,000-4,437,000-10,779,000-18,559,000-13,168,000-9,167,000-13,315,000-5,664,0008,638,0002,391,000-11,902,0001,485,000
Earnings
Jun 18, 2025

Profile

ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; and Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation. The company was founded in 2005 and is headquartered in Uppsala, Sweden.
URL
https://scandidos.com/
IPO date
Apr 11, 2014
Employees
31
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑042016‑04
Income
Revenues
60,429
-1.82%
61,550
6.70%
Cost of revenue
15,123
13,864
Unusual Expense (Income)
NOPBT
45,306
47,686
NOPBT Margin
74.97%
77.48%
Operating Taxes
(98)
Tax Rate
NOPAT
45,306
47,784
Net income
(14,647)
60.62%
(9,119)
24.27%
Dividends
Dividend yield
Proceeds from repurchase of equity
12,450
BB yield
-12.64%
Debt
Debt current
(10,946)
Long-term debt
Deferred revenue
Other long-term liabilities
3,282
737
Net debt
(1,531)
(14,975)
Cash flow
Cash from operating activities
1,485
(11,902)
CAPEX
(4,407)
Cash from investing activities
(2,943)
(4,367)
Cash from financing activities
12,333
FCF
26,042
47,117
Balance
Cash
1,531
3,546
Long term investments
483
Excess cash
952
Stockholders' equity
(116,994)
(119,627)
Invested Capital
164,563
151,068
ROIC
28.71%
35.85%
ROCE
95.24%
151.67%
EV
Common stock shares outstanding
45,609
45,609
Price
1.72
-20.37%
2.16
-2.26%
Market cap
78,447
-20.37%
98,515
7.52%
EV
76,916
83,540
EBITDA
47,622
53,012
EV/EBITDA
1.62
1.58
Interest
1,156
793
Interest/NOPBT
2.55%
1.66%